Vaccine Targets Manufacturers, Suppliers & Companies
-
Manufacturerbased in New Delhi, INDIA
Takara Bio companies provide kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, DSS Takara Bio India Private Ltd. is part of a company that holds ...
Takara - Model SARS-CoV-2 - Novel Vaccines
SARS-CoV-2 research is happening at breakneck speed, and scientists are trying to identify epitopes that could trigger an immune response to the virus, an important step in the development of novel vaccines. Takara Bio offers an ...
CONTACT SUPPLIER -
Manufacturerbased in REDWOOD CITY, CALIFORNIA (USA)
EnGen Bio is developing a therapy and vaccine to provide lifetime immunity to Type A flu. We´ve discovered influenza´s ¨Achille´s heel¨ Unlike conventional flu vaccines, which are generally hemagglutinin or whole-virus based, our vaccine targets a ...
EnGen Bio - Model M1 and M2 - Type A Influenza Protein
represents a vaccine target. We have determined that it is critical to engineer the immunogen to allow the immune system to focus its response on the surface-exposed, highly conserved, M1 epitope. Once the immune ...
CONTACT SUPPLIER -
Manufacturerbased in Addison, TEXAS (USA)
VITRUVIAN BioMedical, Inc is a biotechnology company focused on a unique Business Strategy based on Early, Medium and Late Stage product development. We are committed to providing 'Advance Personalized Medicine' to medical professionals and patients ...
Vitruvian - Model YM7555 - Therapeutic Vaccine for Prevention of Alzheimer`s Disease
VITRUVIAN has obtained the Exclusive Global License for a Therapeutic Vaccine for the Prevention of Alzheimer's Disease. YM7555 - Alzheimer’s Disease Therapeutic Vaccine targeting ABeta and ...
CONTACT SUPPLIER -
Manufacturerbased in Seattle, WASHINGTON (USA)
Icosavax is dedicated to advancing vaccines against severe life-threatening respiratory diseases to protect our most at-risk populations. We are committed to developing safe and effective vaccines against infectious diseases that address important ...
Icosavax - Model IVX-A12 - RSV/hMPV Bivalent VLP Vaccine Candidate
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. ...
CONTACT SUPPLIER -
Technologybased in Abingdon, UNITED KINGDOM
Thermally Stable Needle Free Solid Dose Vaccines. Enesi Pharma is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies. These diseases affect millions of ...
Enesi ImplaVax - Enabled Vaccination Technology
We are focused on the development of the next-generation of vaccination products targeting serious diseases, using our proprietary ImplaVax® solid dose formulation and needle-free delivery ...
CONTACT SUPPLIER -
Manufacturerbased in , CALIFORNIA (USA)
AIVITA Biomedical is a biotechnology company developing personalized vaccines that target COVID-19 and the seed of all cancers using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity ...
AIVITA - Cancer Immunotherapy
AIVITA’s immunotherapy technology creates personalized vaccines for cancer patients that target and eliminate tumor-initiating cells which are the seed of the disease. Used alone or in parallel with other ...
CONTACT SUPPLIER -
Manufacturerbased in Dos Hermanas (Sevilla), SPAIN
Vaxdyn was founded in 2011 as a spin-off established by researchers of the Institute of Biomedicine of Seville, a center of the Andalusian Public Health System and the University of Seville linked to the University Hospital Virgen del Rocío of ...
-
Manufacturerbased in Boston, MASSACHUSETTS (USA)
We harness the natural power of the lymph nodes to generate enhanced immune responses against tumors. Our science is defining the future of immunotherapy, with the goal of giving patients who are battling cancer their best possible outcome. We’re ...
Elicio - Model ELI-007 - Multivalent Lymph Node–Targeted AMP Peptide Vaccine
ELI-007 is a multivalent lymph node–targeted AMP peptide vaccine developed to target BRAF gene mutations. The BRAF gene is part of an intracellular signaling pathway that drives cell ...
CONTACT SUPPLIER -
Manufacturerbased in Nantes, FRANCE
OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases. Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics ...
CoVepiT - Multi-Target and Multi-Variant Vaccine
CoVepiT, a multi-target and multi-variant vaccine candidate against COVID-19. CoVepiT is a next-generation multi-target, multi-variant vaccine against SARS-CoV-2 in clinical Phase ...
CONTACT SUPPLIER -
Manufacturerbased in Pearl River, NEW YORK (USA)
Auro Vaccines LLC is a clinical-stage vaccine development company pioneering a major evolutionary step in the design and development of preventive and therapeutic vaccines for infectious diseases. Our novel approach is based on a proprietary ...
Auro - Model PBS VAX - Preclinical-Stage Therapeutic Vaccines for HBV
Auro Vaccines has also developed a GeneVax prime/VesiculoVax boost therapeutic vaccine that targets all eight HBV genotypes for use as an adjunct to drug ...
CONTACT SUPPLIER -
Manufacturerbased in Woodland, CALIFORNIA (USA)
Hygieia Biological Laboratories was started in 1991 by biologist James Wallis as a research and development laboratory for the investigation of animal diseases and development of new vaccines using novel technology. Since the start up of the ...
-
Manufacturerbased in Nanjing, CHINA
Founded in 2013, Frontier Biotechnologies Inc. (“Frontier Biotech”) is a commercial-stage biopharmaceutical company headquartered in China with global vision and world-class competitiveness. Frontier Biotech is committed to discovering, development, ...
Frontier - Model FB6001 - Investigational Therapeutic Peptide Vaccine
Licensed with exclusive rights for greater China from AFFiRiS AG, a clinical-stage biotechnology company in Austria, FB6001 is an investigational therapeutic peptide vaccine targeting PCSK9 to treat ...
CONTACT SUPPLIER -
Manufacturerbased in Dartmouth, NOVA SCOTIA (CANADA)
We Advance Novel Immunotherapies for Hard-to-Treat Cancers. IMV Inc. is a clinical-stage pharmaceutical company that has the potential to make history by developing a first-in-class effective T cell-targeted immune therapy for cancer. We have built ...
IMV - Model DPX-RSV - DPX-based Vaccine
DPX-RSV or DPX-RSV(A) is a DPX-based vaccine candidate targeting the respiratory syncytial virus (RSV) strain A. The DPX platform is formulated with the SHe peptide of group A RSV. The small hydrophobic glycoprotein ...
CONTACT SUPPLIER -
Manufacturerbased in Acton, AUSTRALIA
Lipotek is a developer of targeted vaccine delivery and adjuvant technologies. There is an undeniable need for technological solutions for prophylactic and therapeutic vaccination against pathogens, cancer and other diseases that have limited or no ...
-
Technologybased in Woburn, MASSACHUSETTS (USA)
We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and ...
Aphios - Vaccine Adjuvant Technology
. There are several types of adjuvants with different modes of action. Adjuvants form a depot of antigen at the site of inoculation with slow release of antigens. Adjuvants can improve the performance of vaccines by ...
CONTACT SUPPLIER -
Technologybased in Phoenix, ARIZONA (USA)
BacVax, Inc., a Delaware corporation with headquarters in Phoenix, Arizona, is developing vaccines against bacteria. BacVax holds an Exclusive Patent License Agreement to use the BVP platform in conjunction with additional patent applications ...
BacVax - Commercial Bacterial Vaccines
Current commercial bacterial vaccines use toxin neutralization, capsule targeting, or multiple proteins. While these methods may work in some circumstances, many bacteria do not have toxin or capsule ...
CONTACT SUPPLIER -
Manufacturerbased in Brooklyn, NEW YORK (USA)
Calder Biosciences, Inc. is a nano-scale molecular engineering company that is applying its platform technology to develop novel respiratory syncytial virus (RSV) and universal Influenza vaccines that both represent multi-billion dollar market ...
Calder - Subunit Vaccines
Targeted approach, focused responses. Substantially reduced risk vis-à-vis other modalities. Successful recombinant subunit vaccines elicit the highest. Ab responses; Shingrix vs. Zostavax, Gardasil, HBsAg ...
CONTACT SUPPLIER -
Technologybased in Hørsholm, DENMARK
We are an AI-immunology platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases. We have developed our AI-immunology core technology to deeply understand the biological ...
Evaxion EDEN - Second AI Platform - Prophylactic Vaccine
EDEN is our second AI platform that rapidly identifies novel, highly protective antigens for the use in pathogen-specific prophylactic vaccines against bacteria. EDEN has been designed to rapidly identify those antigens that will ...
CONTACT SUPPLIER -
Manufacturerbased in Grand Forks, NORTH DAKOTA (USA)
NovaDigm is developing innovative immunotherapeutics and preventative vaccines to protect patients from fungal and bacterial disease, which can be recurrent, drug-resistant and in some cases, life-threatening. NovaDigm’s lead development candidate, ...
Skin and Soft Tissue Infections (SSTI) Cause
Staphylococcus aureus (S. aureus) is the leading cause of skin and soft tissue infections (SSTI), also referred to as skin and skin structure infections. Methicillin-resistant S. aureus (MRSA) is a predominant cause of hospital- and ...
CONTACT SUPPLIER -
Software vendorbased in Oslo, NORWAY
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning based software, which addresses the key knowledge gaps in the prediction of bona fide immunogenic antigens for personalized cancer ...
NEC - Neoantigens Enable Personalized Cancer Immunotherapy Technology
Recent advances in the field of immuno-oncology have established that mutated antigens (neoantigens), are viable targets of the immune system, potentially specific to each individual cancer patient. This plus many other ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you